Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.99.1 (
NADPH-diaphorase
)
3,903
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently, it has been shown for mouse skeletal muscle that
caveolin-3
is localized in the sarcolemma and cofractionates with the original dystrophin complex (DC). In order to find out whether
caveolin-3
is a further component of the recently established and enlarged nitric oxide synthase (NOS) I-DC and whether members of this complex interact with and are potentially regulated by
caveolin-3
, mammalian and non-mammalian healthy and diseased (dystrophic) skeletal muscles were investigated using
caveolin-3
, NOS I, DC components and myosin immunohistochemistry as well as NOS I-associated
diaphorase
histochemistry. In healthy mammalian skeletal muscle,
caveolin-3
was colocalized with the DC components in all extra- and intrafusal fibers. By contrast, NOS I was absent in type I extrafusal fibers of certain species. In patients with Duchenne muscular dystrophy and mdx mice the components of the NOS I-DC were not detected in all extra- and intrafusal fiber types, while
caveolin-3
was found unchanged. In healthy non-mammalian skeletal muscle, i.e. of birds, reptiles and fishes,
caveolin-3
immunoreactivity was lacking in the sarcolemma as was alpha-sarcoglycan; the other NOS I-DC components were either present or absent. In conclusion, although
caveolin-3
is localized in the sarcolemma of mammalian myofibers, there are differences in the microarchitecture of the components of the DC complex and of
caveolin-3
which does not appear to be linked with the NOS I-DC. Potential regulatory interactions between
caveolin-3
and NOS I may nevertheless exist in those fibers where both molecules are colocalized. The absence of
caveolin-3
and alpha-sarcoglycan immunoreactivities in non-mammalian myofibers may suggest that the functions of these proteins are subserved by other components of NOS I-DC complex.
...
PMID:Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle. 954 84
NADPH diaphorase
histochemistry and NOS-1 immunohistochemistry on 60 microm thick frozen sections of rat extensor digitorum longus muscles led to the detection of prominent rings clearly encompassing the surface of the muscle fibres. These so far unknown costameres were usually found as doublets flanking a space of about 2 microm width. Because these costameric doublets did not appear in regular periods, we designate them irregular costameres to discriminate them from regular ones with a 1 microm periodicity overlying Z-discs and M-lines. Irregular costameres were thicker than the regular ones and free of intercostameres. Immunohistochemistry demonstrated that NOS-1 was co-localized with integral (beta-dystroglycan, alpha-sarcoglycan) and peripheral (
caveolin-3
, dystrophin) members of the enlarged dystrophin complex in the irregular costameres but not with non-sarcolemmal organized proteins (myosin heavy chain, alpha-actinin, desmin and sarcoplasmic reticulum-located Ca2+-dependent ATPase-1). Invaginations of the sarcolemma to form irregular costameres were observed. In teased myofibres the sarcolemma between two following irregular costameres was ballooned, while the irregular costameres themselves clamped the fibres together. Finally, the number of detectable irregular costameres was significantly increased in maximally contracted extensor digitorum longus muscles generated by electric stimulation but decreased in mechanically stretched ones. Combining these observations, we hypothesize that irregular costameres belong to a reserve zone for the sarcolemma necessary for the contraction/relaxation cycle in myofibres.
...
PMID:Irregular costameres represent nitric oxide synthase-1-positive sarcolemma invaginations enriched in contracted skeletal muscle fibres. 1125 90